Flagship HbA1c analyser from ARKRAY improves diabetes testing workflow

Pathology in Practice asked ARKRAY general manager David Eyre to provide insights into overall trends while assessing the current UK situation post-COVID. He offers a solution for speeding up all HbA1c testing, increasing throughput for routine tests while reducing unnecessary testing for variants.

According to the latest edition of the International Diabetes Federation Atlas Report, 8.2% of the UK population aged 20–79 years has some form of diabetes, accounting for almost four million people.1

            When just the incidence of type 1 diabetes in children and adolescents (0–19 years) is taken into account, it points out that the UK has some of the highest number of cases, in the top 10 worldwide, with almost 32,000 per annum. The UK is also fifth in the world for incidences of adult-onset type 1 diabetes, below Eritrea, Ireland, Sweden and Finland.

Impact of HbA1c testing

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024